These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21088133)

  • 21. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.
    Otsuru S; Gordon PL; Shimono K; Jethva R; Marino R; Phillips CL; Hofmann TJ; Veronesi E; Dominici M; Iwamoto M; Horwitz EM
    Blood; 2012 Aug; 120(9):1933-41. PubMed ID: 22829629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta.
    Jeong Y; Daghlas SA; Xie Y; Hulbert MA; Pfeiffer FM; Dallas MR; Omosule CL; Pearsall RS; Dallas SL; Phillips CL
    J Bone Miner Res; 2018 Oct; 33(10):1760-1772. PubMed ID: 29813187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counteracting bone fragility with human amniotic mesenchymal stem cells.
    Ranzoni AM; Corcelli M; Hau KL; Kerns JG; Vanleene M; Shefelbine S; Jones GN; Moschidou D; Dala-Ali B; Goodship AE; De Coppi P; Arnett TR; Guillot PV
    Sci Rep; 2016 Dec; 6():39656. PubMed ID: 27995994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).
    Balk ML; Bray J; Day C; Epperly M; Greenberger J; Evans CH; Niyibizi C
    Bone; 1997 Jul; 21(1):7-15. PubMed ID: 9213002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation.
    Uveges TE; Kozloff KM; Ty JM; Ledgard F; Raggio CL; Gronowicz G; Goldstein SA; Marini JC
    J Bone Miner Res; 2009 May; 24(5):849-59. PubMed ID: 19113917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomechanical, Microstructural and Material Properties of Tendon and Bone in the Young Oim Mice Model of Osteogenesis Imperfecta.
    Chretien A; Couchot M; Mabilleau G; Behets C
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse.
    Misof BM; Roschger P; Baldini T; Raggio CL; Zraick V; Root L; Boskey AL; Klaushofer K; Fratzl P; Camacho NP
    Bone; 2005 Jan; 36(1):150-8. PubMed ID: 15664013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta.
    Shi C; Sun B; Wu H; Zhang R; Wu L; Guo L; Li C; Xi Y; Yuan W; Zhang Y; Xu G
    J Bone Miner Res; 2023 Jan; 38(1):103-118. PubMed ID: 36321807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength.
    Kozloff KM; Carden A; Bergwitz C; Forlino A; Uveges TE; Morris MD; Marini JC; Goldstein SA
    J Bone Miner Res; 2004 Apr; 19(4):614-22. PubMed ID: 15005849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim).
    Carleton SM; McBride DJ; Carson WL; Huntington CE; Twenter KL; Rolwes KM; Winkelmann CT; Morris JS; Taylor JF; Phillips CL
    Bone; 2008 Apr; 42(4):681-94. PubMed ID: 18313376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecundity is impaired in a mouse model of osteogenesis imperfecta.
    Oestreich AK; DeCata JA; Akers JD; Phillips CL; Schulz LC
    Mol Reprod Dev; 2020 Sep; 87(9):927-929. PubMed ID: 32869432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.
    Misof K; Landis WJ; Klaushofer K; Fratzl P
    J Clin Invest; 1997 Jul; 100(1):40-5. PubMed ID: 9202055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The material basis for reduced mechanical properties in oim mice bones.
    Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL
    J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model.
    McCarthy EA; Raggio CL; Hossack MD; Miller EA; Jain S; Boskey AL; Camacho NP
    Pediatr Res; 2002 Nov; 52(5):660-70. PubMed ID: 12409511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Marrow Transplantation for Treatment of the Col1a2
    Lee LR; Peacock L; Ginn SL; Cantrill LC; Cheng TL; Little DG; Munns CF; Schindeler A
    Calcif Tissue Int; 2019 Apr; 104(4):426-436. PubMed ID: 30535573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Col1A-2 Mutation in Osteogenesis Imperfecta Mice Contributes to Long Bone Fragility by Modifying Cell-Matrix Organization.
    André G; Chretien A; Demoulin A; Beersaerts M; Docquier PL; Behets C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.
    Yao X; Carleton SM; Kettle AD; Melander J; Phillips CL; Wang Y
    Ann Biomed Eng; 2013 Jun; 41(6):1139-49. PubMed ID: 23536112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OIM and related animal models of osteogenesis imperfecta.
    Shapiro JR; Mcbride DJ; Fedarko NS
    Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
    Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
    Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
    Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
    Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.